Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics

@article{Rosei2007MetabolicPO,
  title={Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics},
  author={Prof. Enrico Agabiti Rosei and Damiano Rizzoni},
  journal={Drugs},
  year={2007},
  volume={67},
  pages={1097-1107}
}
β-Adrenoceptor antagonists (β-blockers) have historically been considered an effective and safe option for first-line treatment of hypertension. However, very recently, it has been proposed that β-blockers should no longer be considered suitable for first-line therapy in the patient with uncomplicated hypertension because of unfavourable morbidity and mortality data. New evidence from recent clinical studies of nebivolol, a third-generation highly selective β1-blocker with additional… CONTINUE READING
26 Citations
29 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Beta - blocking 10 . SENIORS , data on file

  • S Jacob, B Balletshofer, EJ Henriksen
  • 2006

, et al . Clinical cardiovascular disease

  • VI Makolkin, OO Akhmedova, VI Buval’tsev
  • Am J Hypertens
  • 2005

Antihypertensivefects of atenolol vs . nebivolol

  • SS Steiner, AJ Friedhoff, BL Wilson
  • Eur J Heart Fail
  • 2003

Nebivolol : a in hypertensive patients with dyslipidemia : a pilot study

  • MA Broeders, PA Doevendans, BC Bekkers
  • Jthird - generation beta - blocker that augments…
  • 2003

Nebivolol reverses endo - Russian ]

  • N Tzemos, PO Lim, TM MacDonald
  • Kardiologiia
  • 2003

β - Blockers for heart failure : why , which , when , Medical and Surgical Sciences , Clinica Medica , University and where

  • Cleland JGF
  • Med Clin North Am
  • 2003

Similar Papers

Loading similar papers…